CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vivozon Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vivozon Pharmaceutical Co Ltd
34-40, Jeyakgongdan 2-gil, Hyangnam-eup
Phone: +82 234347600p:+82 234347600 YONGIN, 18622  South Korea Ticker: 082800082800
Business Summary
Vivozon Pharmaceutical Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of finished pharmaceutical products. The Company mainly engages in the business of ethical (ETC) drugs, over the counter (OTC) drugs, contract manufacture organization (CMO), original equipment manufacturer (OEM), and other overseas exports. The Company manufactures and sells ETC drugs such as circulatory system drugs, external skin preparations, antipyretics, analgesics, anti-inflammatory drugs, and antidiabetic drugs, as well as OTC drugs such as Lalaola, Inipoten, and Libertine, an adjuvant treatment for liver disease. In addition, the Company manufactures and supplies influenza drugs, digestive drugs, arteriosclerosis drugs, and central nervous system drugs. The Company also manufactures medical devices.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Bu HwanJang 55 6/30/2023 6/30/2023
Internal Auditor Dae SikHong 58
Internal Auditor Hwan SikMok 61 3/18/2010 3/18/2010
5 additional Officers and Directors records available in full report.

Business Names
Business Name
082800
Lumi Micro Co., Ltd.

General Information
Number of Employees: 42 (As of 9/30/2020)
Outstanding Shares: 49,379,445 (As of 12/31/2024)
Shareholders: 23,071
Stock Exchange: KDQ
Fax Number: +82 312107905


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025